| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 224.51M | $ 199.00M | $ 335.30M | $ 277.20M | $ 262.06M |
| Gross Profit | $ 82.14M | $ 69.10M | $ 112.90M | $ 114.80M | $ 88.06M |
| Operating Income | $ 21.10M | $ -6.50M | $ 5.30M | $ 22.10M | $ 5.84M |
| EBITDA | $ 39.63M | $ 36.60M | $ 49.70M | $ 81.90M | $ 59.30M |
| Net Income | $ -23.47M | $ 180.30M | $ -9.00M | $ 10.00M | $ -8.01M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 16.90M | $ 15.00M | $ 27.50M | $ 21.00M | $ 11.10M |
| Total Assets | $ 388.98M | $ 380.30M | $ 827.20M | $ 821.10M | $ 757.45M |
| Total Debt | $ 182.10M | $ 147.50M | $ 393.00M | $ 381.20M | $ 324.80M |
| Net Debt | $ 165.20M | $ 132.50M | $ 365.50M | $ 360.20M | $ 313.70M |
| Total Liabilities | $ 245.00M | $ 213.50M | $ 460.60M | $ 443.70M | $ 387.10M |
| Stockholders' Equity | $ 144.00M | $ 166.90M | $ 366.50M | $ 378.80M | $ 370.36M |
| Cash Flow | |||||
| Free Cash Flow | $ -1.75M | $ -5.20M | $ -1.90M | $ -31.00M | $ -78.52M |
| Operating Cash Flow | $ 4.53M | $ 12.20M | $ 47.40M | $ 15.10M | $ 2.59M |
| Investing Cash Flow | $ -17.29M | $ 379.40M | $ -48.90M | $ -56.40M | $ -81.10M |
| Financing Cash Flow | $ 14.72M | $ -404.00M | $ -12.00M | $ 52.50M | $ 78.94M |
Aker BioMarine ASA (DE:1PG)
STUTTGART:1PG
